Investment Analysts’ Recent Ratings Updates for Principia Biopharma (PRNB)



  • Summary:

     

    Principia Biopharma (NASDAQ: PRNB) has recently received a number of price target changes and ratings updates:

    12/19/2019 – Principia Biopharma had its price target raised by analysts at Stifel Nicolaus from $51.00 to $66.00. They now have a “buy” rating on the stock.

    12/10/2019 – Principia Biopharma was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating.

    12/9/2019 – Principia Biopharma had its “buy” rating reaffirmed by analysts at Stifel Nicolaus.

    12/9/2019 – Principia Biopharma had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.

    11/19/2019 – Principia Biopharma was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating.

    11/9/2019 – Principia Biopharma was downgraded by analysts a ...

     

     

    Read Full News: https://slatersentinel.com/news/2020/01/15/investment-analysts-recent-ratings-updates-for-principia-biopharma-prnb-updated-updated-updated.html


Log in to reply